Insider sales by Madrigal (MDGL) include 24,800 and 18,650-share trades

Rhea-AI Filing Summary

Madrigal Pharmaceuticals submitted Rule 144 notices reporting proposed and recent sales of Common Stock by insiders. The filing lists multiple historical sales, including 18,650 shares sold by Rebecca A. Taub on 01/09/2026 and 24,800 shares sold by Paul A. Friedman on 01/09/2026 The excerpt also shows a restricted stock unit vesting of 491 shares on 03/06/2026.

Insights

Insider Transactions Analyst

Rule 144 notices list specific insider sales and a RSU vesting.

The filing records multiple past sales by named insiders with per‑trade share counts and dollar values for several transactions. It also lists a 491 share restricted stock unit vesting on 03/06/2026.

These are regulatory notices of resale activity; the listed sale dates and share counts are primary facts investors can verify in public filings and transaction records.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza, 8th Floor New York NY 10004	491	215715.94	22939969	03/06/2026	Nasdaq Stock Market

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	03/05/2026	Restricted Stock Unit Grant	Issuer			491	03/06/2026	Vesting of Restricted Stock Units

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
REBECCA A TAUB c/o Madrigal Pharmaceuticals, Inc. 200 Barr Harbor Drive, Suite 200 West Conshohocken PA 19428	Common Stock	01/26/2026	647	318595.74
REBECCA A TAUB c/o Madrigal Pharmaceuticals, Inc. 200 Barr Harbor Drive, Suite 200 West Conshohocken PA 19428	Common Stock	01/20/2026	2238	1098343.26
REBECCA A TAUB c/o Madrigal Pharmaceuticals, Inc. 200 Barr Harbor Drive, Suite 200 West Conshohocken PA 19428	Common Stock	01/09/2026	18650	9749391.94
REBECCA A TAUB c/o Madrigal Pharmaceuticals, Inc. 200 Barr Harbor Drive, Suite 200 West Conshohocken PA 19428	Common Stock	12/10/2025	18650	10297573.26
Sales for PAUL A FRIEDMAN c/o Madrigal Pharmaceuticals, Inc. 200 Barr Harbor Drive, Suite 200 West Conshohocken PA 19428	Common Stock	01/09/2026	24800	12963304.72
Sales for PAUL A FRIEDMAN c/o Madrigal Pharmaceuticals, Inc. 200 Barr Harbor Drive, Suite 200 West Conshohocken PA 19428	Common Stock	12/10/2025	24800	13694158.24

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the MDGL Form 144 filing report?

The filing reports proposed and recent resale transactions of MDGL common stock by insiders. It lists multiple past sales with dates, share counts, and dollar amounts, and shows a restricted stock unit vesting of 491 shares on 03/06/2026.

How many shares did Rebecca A. Taub sell according to the filing?

The filing lists several sales by Rebecca A. Taub, including 18,650 shares on 01/09/2026 and additional sales of 18,650, 2,238, and 647 shares on earlier dates with accompanying dollar amounts.

What sales by Paul A. Friedman appear in the MDGL excerpt?

The excerpt shows Paul A. Friedman sold 24,800 shares on both 01/09/2026 and 12/10/2025, with dollar values listed for each transaction alongside the share counts in the filing.

Does the filing show any equity grants or vesting for MDGL insiders?

Yes. The filing includes a line showing a Restricted Stock Unit grant and the vesting of 491 shares dated 03/05/2026/03/06/2026 as the issuer action shown in the excerpt.